News

Results in Line with Guidance

The addition of the Hologic Aptima HPV 16 18/45 genotype assay completes the HPV portfolio on the popular and fully automated laboratory system

Hologic 3D technology tops "Minnies" and "Best in KLAS" annual awards

MammoSite APBI Demonstrates Excellent Cosmesis and Low Local Recurrence

Jack Cumming, Hologic's CEO, will discuss the impact of Hologic's 3D mammography technology and efforts to raise awareness of breast cancer during the month of October

Hologic's Horizon DXA platform is designed from the bottom up to include the latest in technical capabilities and workflow efficiencies for now and for the future

Revenues In-line with and EPS Exceeding Guidance as Pre-Announced

Interest rate on Term Loan B reduced by 75 basis points

Single Energy Femur Exam option allows clinicians to visualize features associated with developing atypical femur fractures, a debilitating fracture associated with bisphosphonate therapy

The addition of Hologic's Aptima HPV assay to the fully-automated Panther system expands the ability of laboratories to run multiple tests from a single specimen.

Robert Cascella Will Remain Advisor to Company Through November 2013

Prone and upright guidance systems, biopsy device utilizing 3D, stereotactic, ultrasound or MRI guidance, site markers and specimen radiography from a single vendor

Six-year contract with large Belgium lab includes the purchase of Hologic ThinPrep test and automated processing equipment

New contracts include usage of ThinPrep Pap Test and Imaging System in all NHS cytology laboratories in Scotland